Fjarde Ap Fonden Becton Dickinson & CO Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fjarde Ap Fonden holds 61,646 shares of BDX stock, worth $13.9 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

61,646

Previous 70,246 12.24%

Holding current value

$13.9 Million

Previous $17.4 Million 14.49%

% of portfolio

0.15%

Previous 0.19%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$221.47 - $242.41 $1.9 Million - $2.08 Million	-8,600 Reduced 12.24%	61,646 $14.9 Million
Q1 2024 Apr 25, 2024	BUY	$233.45 - $247.73 $840,420 - $891,828	3,600 Added 5.4%	70,246 $17.4 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $464,480 - $534,460	-2,000 Reduced 2.91%	66,646 $16.3 Million
Q3 2023 Oct 23, 2023	SELL	$254.9 - $283.59 $1.07 Million - $1.19 Million	-4,200 Reduced 5.77%	68,646 $17.7 Million
Q2 2023 Aug 02, 2023	BUY	$238.39 - $265.32 $4.41 Million - $4.91 Million	18,500 Added 34.04%	72,846 $19.2 Million
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $1.45 Million - $1.63 Million	-6,300 Reduced 10.39%	54,346 $13.5 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $152,803 - $179,837	700 Added 1.17%	60,646 $15.4 Million
Q2 2022 Aug 11, 2022	BUY	$234.74 - $275.42 $516,428 - $605,924	2,200 Added 3.81%	59,946 $14.8 Million
Q1 2022 May 13, 2022	SELL	$243.64 - $270.48 $4.56 Million - $5.06 Million	-18,700 Reduced 24.46%	57,746 $15.4 Million
Q4 2021 Feb 15, 2022	SELL	$230.08 - $250.94 $1.01 Million - $1.1 Million	-4,400 Reduced 5.44%	76,446 $19.2 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $490,806 - $540,895	-2,109 Reduced 2.54%	80,846 $19.9 Million
Q2 2021 Aug 12, 2021	SELL	$232.65 - $254.58 $1.63 Million - $1.78 Million	-7,000 Reduced 7.78%	82,955 $20.2 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $1.02 Million - $1.13 Million	4,400 Added 5.14%	89,955 $21.9 Million
Q4 2020 Feb 12, 2021	SELL	$221.92 - $245.94 $821,104 - $909,978	-3,700 Reduced 4.15%	85,555 $21.4 Million
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $2.55 Million - $3.27 Million	11,800 Added 15.23%	89,255 $20.8 Million
Q2 2020 Aug 13, 2020	BUY	$219.9 - $263.41 $197,910 - $237,069	900 Added 1.18%	77,455 $18.5 Million
Q1 2020 May 11, 2020	SELL	$195.69 - $279.01 $763,191 - $1.09 Million	-3,900 Reduced 4.85%	76,555 $17.6 Million
Q4 2019 Feb 10, 2020	BUY	$236.45 - $266.82 $1.56 Million - $1.76 Million	6,600 Added 8.94%	80,455 $21.9 Million
Q3 2019 Oct 31, 2019	SELL	$230.58 - $256.08 $678,596 - $753,643	-2,943 Reduced 3.83%	73,855 $18.7 Million
Q2 2019 Jul 17, 2019	SELL	$217.4 - $246.08 $673,940 - $762,848	-3,100 Reduced 3.88%	76,798 $19.4 Million
Q1 2019 Apr 29, 2019	BUY	$206.05 - $248.17 $3.31 Million - $3.99 Million	16,068 Added 25.17%	79,898 $20 Million
Q4 2018 Jan 31, 2019	SELL	$204.73 - $257.93 $1.76 Million - $2.22 Million	-8,600 Reduced 11.87%	63,830 $14.4 Million
Q3 2018 Nov 09, 2018	SELL	$233.07 - $256.0 $637,679 - $700,416	-2,736 Reduced 3.64%	72,430 $18.9 Million
Q2 2018 Jul 12, 2018	BUY	$208.1 - $233.85 $634,080 - $712,540	3,047 Added 4.22%	75,166 $18 Million
Q1 2018 May 07, 2018	SELL	$205.46 - $240.27 $242,648 - $283,758	-1,181 Reduced 1.61%	72,119 $15.6 Million
Q4 2017 Feb 12, 2018	BUY	$189.0 - $222.64 $3.64 Million - $4.28 Million	19,241 Added 35.59%	73,300 $15.7 Million
Q3 2017 Nov 07, 2017	BUY	$186.89 - $198.9 $241,274 - $256,779	1,291 Added 2.45%	54,059 $10.6 Million
Q2 2017 Aug 08, 2017	BUY	N/A	52,768	52,768 $10.3 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account